Wegovy Savings Card: Who Qualifies and What It Actually Covers
How the Wegovy savings card works in 2026: eligibility rules, benefit caps, program risks, and what your options are if you do not qualify.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. This analysis walks through the Wegovy savings card program: who it covers, what it caps, and what to do if you fall outside its eligibility rules.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Understanding the Wegovy Savings Card
The Wegovy savings card is a manufacturer-sponsored copay assistance program from Novo Nordisk designed to reduce the out-of-pocket cost of brand-name Wegovy for eligible patients. On paper, the program sounds generous, and for patients who qualify, it can meaningfully reduce monthly costs. However, the eligibility requirements, benefit caps, and fine print mean that the savings card is not a universal solution to Wegovy's high price.
The most important limitation is that the savings card requires commercial insurance that already covers Wegovy. It does not transform an uninsured patient into one who can afford Wegovy, it supplements existing coverage by reducing the copay portion. Patients without insurance, those on government insurance programs (Medicare, Medicaid, Tricare), and those whose commercial plans do not cover Wegovy cannot use the card at all.
This means the savings card helps a relatively narrow population: commercially insured patients whose plans cover Wegovy but impose copays that make the medication expensive. For everyone else, which represents the majority of people seeking semaglutide for weight loss, the savings card offers no benefit at all, and the practical next step is asking a licensed provider which treatment routes are actually open to you, including compounded semaglutide through Trimi.
Where the Savings Card Applies, Scenario by Scenario
| Scenario | Savings Card Applies? | What You Pay for Wegovy |
|---|---|---|
| Insured, plan covers Wegovy | Yes, while the card is active | $0 - $25/mo copay |
| Insured, plan does NOT cover Wegovy | No, coverage is a prerequisite | Full retail, $1,300+/mo |
| Uninsured | No, commercial insurance required | Full retail, $1,300+/mo |
| Medicare/Medicaid | No, government plans are excluded | Varies by plan formulary |
| After savings card cap reached | No, annual benefit exhausted | $200 - $500/mo insurance copay |
| Annual total (insured, card works all year) | Yes | $0 - $300/yr plus premiums |
| Annual total (uninsured) | No | $15,600+/yr at retail |
Key Takeaway
The savings card only helps commercially insured patients whose plans cover Wegovy and who have not exhausted the annual benefit cap. Everyone else is quoted the plan copay or full retail, so confirm your eligibility before you build a budget around the card.
When the Savings Card Makes Sense
To be fair, the Wegovy savings card is a valuable tool for patients who qualify. If you have commercial insurance that covers Wegovy, the savings card can reduce your monthly copay to near zero, making brand-name Wegovy essentially free beyond your regular insurance premiums. For this specific population, the savings card plus insurance is the least expensive way to access semaglutide.
You have commercial (employer or marketplace) insurance that covers Wegovy
Your plan requires a copay rather than covering Wegovy at 100%
You have not yet reached the savings card annual benefit cap
The savings card program is currently active and accepting enrollments
You do not mind the potential for the program to change or end
When Compounded Semaglutide Makes Sense
For the majority of patients, those without commercial insurance that covers Wegovy, compounded semaglutide is one of the routes worth raising with a provider. It tends to suit patients who value predictability, simplicity, and independence from insurance and manufacturer programs that can change without notice.
You do not have insurance, or your insurance does not cover Wegovy
You are on Medicare, Medicaid, or other government insurance
Your insurance copay for Wegovy is high enough that you are reconsidering the brand route
You prefer predictable monthly pricing not subject to program changes
You want to avoid the hassle of prior authorization and insurance appeals
You value month-to-month flexibility without contracts or coverage requirements
You have experienced Wegovy supply shortages affecting your treatment
You want specialized weight management support from board-certified providers
Through Trimi, compounded semaglutide at $99 per month includes everything, medication, provider consultations, medical oversight, and shipping. No insurance needed, no savings cards to manage, no annual benefit caps to worry about. Compounded semaglutide is prepared per individual prescription and is not FDA-approved as a drug.
The Hidden Risks of Relying on Savings Cards
Patients who rely on manufacturer savings cards should be aware of several risks that can disrupt their treatment and finances unexpectedly.
Programs can be modified or discontinued by the manufacturer at any time
Annual benefit caps mean costs can spike partway through the year
Insurance coverage changes at annual renewal can affect savings card eligibility
Job changes or insurance plan switches can eliminate eligibility overnight
The savings card creates dependency on a promotional program rather than sustainable pricing
Compounded semaglutide pricing through Trimi is not dependent on any promotional program, insurance coverage, or manufacturer goodwill. The price reflects the actual cost of the medication and service, making it a sustainable long-term solution rather than a temporary promotional benefit.
Bottom Line
The Wegovy savings card is valuable for the specific subset of patients who have commercial insurance covering Wegovy. For everyone else, uninsured patients, those on government insurance, those whose plans do not cover Wegovy, and those who have exceeded their savings card benefit, compounded semaglutide at $99 per month through Trimi is one route that does not depend on a benefit program, though it is not FDA-approved as a drug.
Even patients currently using the savings card should have a backup plan. If your insurance changes, the program ends, or you hit the annual cap, knowing that compounded semaglutide is available ensures you can continue treatment without interruption. For many patients, the simplicity and predictability of compounded pricing makes it the preferred choice from day one.
Frequently Asked Questions
How does the Wegovy savings card work?
The Wegovy savings card from Novo Nordisk reduces the copay for commercially insured patients who have insurance coverage for Wegovy. When eligible, the card can bring monthly copays as low as $0 to $25. However, the card requires commercial insurance that covers Wegovy as a prerequisite, has a maximum annual benefit cap, and is not available to patients on Medicare, Medicaid, or those without insurance.
Can I use the Wegovy savings card without insurance?
No, the Wegovy savings card requires commercial insurance coverage for Wegovy. Patients without insurance cannot use the savings card. Uninsured patients sometimes ask a provider about compounded semaglutide, which is dispensed on a cash-pay basis at $99 per month through providers like Trimi and does not require insurance coverage. It is not FDA-approved as a drug.
Does the Wegovy savings card have a maximum benefit?
Yes, the Wegovy savings card has a maximum annual benefit amount, after which patients revert to their standard insurance copay. The specific maximum varies by program terms and can change. Once the cap is reached, patients may face significantly higher costs for the remainder of the year. Compounded semaglutide pricing remains consistent month to month without any benefit caps.
What are my options if I do not qualify for the Wegovy savings card?
If you do not have commercial insurance that covers Wegovy, the savings card cannot be applied at all. The practical routes at that point are Novo Nordisk's patient assistance program if you meet the income criteria, a formal appeal if you have coverage but were denied, or asking a licensed provider about compounded semaglutide, which is dispensed on a cash-pay basis at $99 per month through Trimi and is not FDA-approved as a drug.
Who qualifies for the Wegovy savings card?
Eligibility typically requires commercial insurance that covers Wegovy, US residency, and being 18 or older. Patients on Medicare, Medicaid, Tricare, or other government-funded insurance programs are generally excluded. Patients whose insurance does not cover Wegovy or who have no insurance are also ineligible. Eligibility criteria can change, so always verify current requirements on Novo Nordisk's website.
Can the Wegovy savings card expire or be discontinued?
Yes, savings card programs have expiration dates and Novo Nordisk can modify or discontinue the program at any time. Patients relying on the savings card should be aware that their cost could increase significantly if the program changes. Compounded semaglutide through Trimi offers consistent, predictable pricing that does not depend on manufacturer promotional programs.
What happens when my Wegovy savings card benefit runs out?
When you reach the maximum annual benefit, you revert to your insurance plan's standard copay for Wegovy, which could be $200 to $500 or more per month depending on your plan. At that point it is worth re-checking your plan's formulary, asking your provider whether an appeal is warranted, and discussing what other treatment options are open to you.
Sources & References
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Trimi offers compounded semaglutide, readers should be aware of our perspective.